caramiphen has been researched along with physostigmine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| Musacchio, JM; Tortella, FC; Witkin, JM | 1 |
| Aas, P; Enger, S; Myhrer, T | 1 |
3 other study(ies) available for caramiphen and physostigmine
| Article | Year |
|---|---|
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Caramiphen: a non-opioid antitussive with potent anticonvulsant properties in rats.
Topics: Animals; Anticonvulsants; Antitussive Agents; Atropine; Behavior, Animal; Cyclopentanes; Electroshock; Injections, Subcutaneous; Male; Phenytoin; Physostigmine; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Antiparkinson drugs used as prophylactics for nerve agents: studies of cognitive side effects in rats.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Benactyzine; Biperiden; Cholinergic Antagonists; Cholinesterase Inhibitors; Cognition; Cyclopentanes; Exploratory Behavior; Male; Motor Activity; Neurotoxins; Organophosphorus Compounds; Physostigmine; Procyclidine; Rats; Rats, Wistar; Trihexyphenidyl | 2008 |